Jane Street Group LLC decreased its position in AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) by 65.8% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 14,106 shares of the insurance provider's stock after selling 27,193 shares during the period. Jane Street Group LLC owned about 0.07% of AMERISAFE worth $727,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in the company. Isthmus Partners LLC raised its holdings in AMERISAFE by 0.5% in the 4th quarter. Isthmus Partners LLC now owns 63,926 shares of the insurance provider's stock valued at $3,295,000 after acquiring an additional 316 shares during the last quarter. Values First Advisors Inc. increased its stake in AMERISAFE by 8.2% in the fourth quarter. Values First Advisors Inc. now owns 5,350 shares of the insurance provider's stock valued at $276,000 after purchasing an additional 404 shares during the last quarter. Bank of Montreal Can lifted its position in AMERISAFE by 4.6% during the fourth quarter. Bank of Montreal Can now owns 9,375 shares of the insurance provider's stock worth $483,000 after buying an additional 410 shares during the period. Illinois Municipal Retirement Fund boosted its stake in AMERISAFE by 4.1% in the 4th quarter. Illinois Municipal Retirement Fund now owns 10,904 shares of the insurance provider's stock worth $562,000 after buying an additional 428 shares during the last quarter. Finally, MetLife Investment Management LLC grew its holdings in AMERISAFE by 6.1% in the 4th quarter. MetLife Investment Management LLC now owns 11,692 shares of the insurance provider's stock valued at $603,000 after buying an additional 669 shares during the period. Hedge funds and other institutional investors own 97.41% of the company's stock.
Analyst Upgrades and Downgrades
Separately, JMP Securities reiterated a "market outperform" rating and set a $65.00 price objective on shares of AMERISAFE in a report on Wednesday, April 30th.
View Our Latest Stock Report on AMERISAFE
AMERISAFE Price Performance
AMSF stock traded up $0.15 during trading on Friday, reaching $47.31. 1,608 shares of the stock traded hands, compared to its average volume of 87,921. The firm has a market capitalization of $901.16 million, a PE ratio of 14.78 and a beta of 0.41. The business's 50 day moving average price is $48.71 and its 200-day moving average price is $51.17. AMERISAFE, Inc. has a 52-week low of $41.97 and a 52-week high of $60.24.
AMERISAFE (NASDAQ:AMSF - Get Free Report) last posted its earnings results on Tuesday, April 29th. The insurance provider reported $0.60 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.59 by $0.01. The firm had revenue of $83.78 million during the quarter, compared to the consensus estimate of $76.66 million. AMERISAFE had a net margin of 19.49% and a return on equity of 16.50%. On average, equities research analysts predict that AMERISAFE, Inc. will post 2.45 earnings per share for the current year.
AMERISAFE Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 13th will be given a $0.39 dividend. This represents a $1.56 annualized dividend and a dividend yield of 3.30%. The ex-dividend date is Friday, June 13th. AMERISAFE's payout ratio is 62.90%.
About AMERISAFE
(
Free Report)
AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Featured Stories

Before you consider AMERISAFE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.
While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.